Biotech Investing Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
Biotech Investing CTD Holdings Finalizes Cooperative Agreement for Alzheimer’s Disease Research Program
Biotech Investing Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase
Biotech Investing CTD Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappsol Cyclo
Biotech Investing AnaptysBio Announces Positive Top-Line Proof-of-Concept Data For ANB020 In Moderate-to-Severe Baseline
Biotech Investing argenx announces expansion of its pipeline with addition of complement-targeted ARGX-117
Biotech Investing ContraFect Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Biotech Investing Capricor Presents Fourth Quarter and Full Year 2017 Financial Results and Corporate Update